Dillard's (DDS) Earnings Analysis
Dillard's (DDS) next reports earnings on 2026-08-13, consensus EPS 4.26 USD. Last quarter (2026-05-14) it beat with EPS 16.04 USD vs 10.37 USD est (+54.7%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 14.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DDS next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | 4.26 USD |
| Revenue estimate | 1.53B |
DDS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 16.04 USD | 10.37 USD | +54.7% | Beat |
| 2025-11-13 | 8.31 USD | 6.18 USD | +34.5% | Beat |
| 2025-08-14 | 4.66 USD | 3.79 USD | +23% | Beat |
| 2025-05-15 | 10.39 USD | 9.14 USD | +13.7% | Beat |
| 2024-11-14 | 7.73 USD | 6.5 USD | +18.9% | Beat |
| 2024-08-15 | 4.59 USD | 5.97 USD | -23.1% | Miss |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
DDS valuation and analyst view
| Trailing P/E | 14.01 |
|---|---|
| Trailing EPS | 42.141 USD |
| Price / book | 4.54 |
| Dividend yield | 5.29% |
| Market cap | 9.00B |
| Analyst consensus | Hold (2 buy / 6 hold / 5 sell) |
| Avg price target | 465 USD |
Related research pages
Frequently asked questions
When is Dillard's (DDS)'s next earnings date?
Dillard's is next scheduled to report on 2026-08-13, with a consensus EPS estimate of 4.26 USD and revenue estimate of 1.53B.
Did DDS beat earnings last quarter?
In its 2026-05-14 report, DDS posted EPS of 16.04 USD versus a 10.37 USD estimate — a beat of 54.7%.
What is DDS's earnings track record?
Over the last 6 reported quarters with consensus data, DDS beat estimates 5 times (83%).
What is DDS's current P/E ratio and EPS?
DDS trades at a trailing P/E of 14.01 on trailing EPS of 42.14102564102564 USD.
What do analysts rate DDS?
Analyst consensus is "Hold" across 13 ratings (0 strong buy, 2 buy, 6 hold, 5 sell, 0 strong sell). Average 12-month price target: 465 USD.